Maciej S Lesniak

  • 10540 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My clinical and research interests focus on neurosurgical management of patients with brain and spinal cord tumors. I take care of patients with both benign as well as malignant cancer of the brain/spinal cord. In addition, part of my practice is devoted to the care of neurovascular patients, including aneurysms and arteriovenous malformations.

Training Experience

1997Internship, Johns Hopkins Hospital
2002Fellowship, Johns Hopkins Hospital
2002Residency, Johns Hopkins Hospital

Education/Academic qualification

MS, Harvard University

… → 2010

MD, Johns Hopkins University

… → 1996

Research interests

  • Acoustic Neuroma
  • Biologic Therapies
  • Brain Aneurysm
  • Brain Arteriovenous Malformation
  • Brain Cancer / Nervous System Cancer
  • Neuro-Oncology
  • Neurosurgery
  • Skull Base Surgery

Fingerprint Dive into the research topics where Maciej S Lesniak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    A Neutrophil-Inspired Supramolecular Nanogel for Magnetocaloric–Enzymatic Tandem Therapy

    Zhang, Q., Wu, J., Wang, J., Wang, X., Wu, C., Chen, M., Wu, Q., Lesniak, M. S., Mi, Y., Cheng, Y. & Wang, Q., Feb 24 2020, In : Angewandte Chemie - International Edition. 59, 9, p. 3732-3738 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Editing Cytoprotective Autophagy in Glioma: An Unfulfilled Potential for Therapy

    Ulasov, I., Fares, J., Timashev, P. & Lesniak, M. S., Mar 2020, In : Trends in Molecular Medicine. 26, 3, p. 252-262 11 p.

    Research output: Contribution to journalReview article

  • 2 Scopus citations

    Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer (Molecular Therapy - Oncolytics (2019) 12 (79–92), (S237277051830038X), (10.1016/j.omto.2018.12.003))

    Mooney, R., Majid, A. A., Batalla-Covello, J., Machado, D., Liu, X., Gonzaga, J., Tirughana, R., Hammad, M., Dellinger, T. H., Lesniak, M. S., Curiel, D. T. & Aboody, K. S., Jun 26 2020, In : Molecular Therapy - Oncolytics. 17, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Evaluation of patient education materials for stereotactic radiosurgery from high-performing neurosurgery hospitals and professional societies

    Rooney, M. K., Rooney, M. K., Golden, D. W., Byun, J., Lukas, R. V., Lukas, R. V., Sonabend, A. M., Lesniak, M. S. & Sachdev, S., Jan 31 2020, In : Neuro-Oncology Practice. 7, 1, p. 59-67 9 p.

    Research output: Contribution to journalArticle

  • GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma

    Rashidi, A., Miska, J., Lee-Chang, C., Kanojia, D., Panek, W. K., Lopez-Rosas, A., Zhang, P., Han, Y., Xiao, T., Pituch, K. C., Kim, J. W., Talebian, M., Fares, J. & Lesniak, M. S., Jan 1 2020, In : Cancer Immunology, Immunotherapy. 69, 1, p. 81-94 14 p.

    Research output: Contribution to journalArticle